DALLAS, April 1, 2021 — Mobile health technology can be beneficial in encouraging lifestyle behavior changes and medication adherence among adults ages 60 and older with existing heart… read more.
BeiGene, Ltd. a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that Brukinsa (zanubrutinib) has been approved by Health Canada for the treatment of… read more.
Article written by Christine Clark. During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and… read more.
Article written by Christine Clark Numerous clinical trials with ivermectin in covid-19 have shown consistent, large magnitude improvements in clinical outcomes that are little short of spectacular but… read more.
Our immune system’s capacity to mount a well-regulated defence against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65..
Article written by Christine Clark Leading scientists propose a ‘more humane’ strategy for the management of the coronavirus pandemic.
Article written by Bruce Sylvester Glycated hemoglobin A1c (HbA1c) greater than 7% correlates with an increased risk of cardiovascular events in elderly patients..
Article written by Bruce Sylvester Elderly patients without atherosclerotic cardiovascular disease (ASCVD) who initiated statin therapy have achieved a 25% reduction in the risk of early death..
Moderna, Inc. announced the publication of an interim analysis of the open-label Phase 1 study of mRNA-1273, its vaccine candidate against COVID-19, in The New England Journal of… read more.
Idorsia Ltd announced positive top-line results of the second pivotal Phase III study investigating 10 and 25 mg doses of its dual orexin receptor antagonist, daridorexant , in… read more.
Article written by Bruce Sylvester
Written by Bruce Sylvester Researchers report that there is no link between statin use and cognitive decline. The findings were published on Nov. 18, 2019 in the Journal… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
